MMP8
MMDA (3-methoxy-4,5-methylenedioxyamphetamine) is a psychedelic and empathogen of the amphetamine class. It is chemically related to MDA and MDMA, and is known for its psychoactive effects.
History[edit | edit source]
MMDA was first synthesized by Alexander Shulgin, a renowned chemist known for his work with psychoactive compounds. Shulgin documented the synthesis and effects of MMDA in his book PiHKAL: A Chemical Love Story.
Chemistry[edit | edit source]
MMDA is a derivative of amphetamine and is structurally similar to MDA and MDMA. It contains a methoxy group at the 3-position and a methylenedioxy group at the 4,5-positions of the phenyl ring. The chemical formula is C11H15NO3.
Pharmacology[edit | edit source]
MMDA acts primarily as a serotonin releasing agent, similar to other compounds in the MDxx class. It is known to produce effects such as altered perception, mood enhancement, and increased empathy. The exact mechanism of action involves the release of serotonin and possibly other neurotransmitters.
Effects[edit | edit source]
The effects of MMDA can include:
- Altered sensory perception
- Enhanced mood and empathy
- Visual and auditory hallucinations
- Increased energy and euphoria
The duration of effects typically lasts 4-6 hours, with onset occurring within 30-60 minutes after ingestion.
Legal Status[edit | edit source]
MMDA is classified as a Schedule I controlled substance in the United States, meaning it is illegal to manufacture, buy, possess, or distribute without a DEA license. It is similarly controlled in many other countries.
Safety and Toxicity[edit | edit source]
There is limited data on the toxicity of MMDA, but it is generally considered to have a safety profile similar to other psychedelic amphetamines. Potential risks include serotonin syndrome, cardiovascular effects, and psychological distress.
Research[edit | edit source]
Research on MMDA is limited, but it has been studied for its potential therapeutic effects in psychotherapy, similar to MDMA. However, due to its legal status, research is restricted.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
